Unlimited and GxP-Ready NGS-Analyses
Genedata Selector
Ensure the quality of Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapies, by using Genedata Selector® to apply next-generation sequencing (NGS) as a multi-attribute method (MAM) for comprehensive quality control (QC). As a GMP-ready NGS analysis software solution, Genedata Selector accelerates the generation of actionable, NGS-driven insights by streamlining data management, processing, analysis and reporting.
The end-to-end, sequencing technology-agnostic software solution centralizes results from diverse NGS assays, automating short- and long-read workflows. With the high sensitivity of NGS and default parameters for AAV, Genedata Selector enables accurate measurement of key parameters such as read metrics while minimizing false positives and false negatives.
With built-in Playbooks that guide sample registration, data integration, sample tracking to analysis and report generation, the solution supports MAM applications for biosafety testing, Critical Quality Attribute (CQA) assessment and adventitious agent detection (AAD). Genedata Selector’s intuitive visualizations enable users across technical backgrounds to interpret NGS data with confidence while ensuring full traceability, auditability, and regulatory compliance from R&D to commercial manufacturing.
In this brochure, discover how Genedata Selector enables biopharma to fully leverage NGS as a MAM approach — delivering efficient, scalable, and compliant genomics-driven product characterization and quality control across global sites.
